About ROSE Diagnostics
ROSE Diagnostics is a private company based in Carlsbad, California, incorporated in 2023 in Delaware. It has reported $5,558,125 raised in three offerings on Form D since June 2024. Its chief executive is Andrew Morris.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 10, 2026 | Sep 15, 2026 | $2,208,750of $3.0M target | 18 | $122K | EquityRule 506(b) | Form D ↗ |
| May 9, 2025 | May 13, 2025 | $2,344,375of $3.0M target | 18 | $130K | EquityRule 506(b) | Form D ↗ |
| Jun 6, 2024 | Jun 21, 2024 | $1,005,000fully sold | 13 | $77,308 | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $5,558,125 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on ROSE Diagnostics's Form D filed Sep 15, 2026.
Sources
- SECROSE DIAGNOSTICS INC. filing history
- CompanyAbout ROSE Diagnostics
- CompanyInvestor relations
- CompanyFunding announcement